Tussionex pennkinetic and Ergocalciferol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tussionex pennkinetic (chlorpheniramine polistirex; hydrocodone polistirex) and Ergocalciferol (ergocalciferol). Common drug interactions include blood pressure increased among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Tussionex pennkinetic and Ergocalciferol. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Tussionex pennkinetic?

Tussionex pennkinetic has active ingredients of chlorpheniramine polistirex; hydrocodone polistirex. It is often used in cough. eHealthMe is studying from 963 Tussionex pennkinetic users. Check the latest studies of Tussionex pennkinetic.

What is Ergocalciferol?

Ergocalciferol has active ingredients of ergocalciferol. It is often used in rickets. eHealthMe is studying from 32,652 Ergocalciferol users. Check the latest studies of Ergocalciferol.

On Jul, 28, 2026

22 people who take Tussionex pennkinetic and Ergocalciferol together, and have interactions are studied.

Tussionex pennkinetic and Ergocalciferol drug interactions.

What are the common drug interactions of Tussionex Pennkinetic and Ergocalciferol, by gender? *:

female:

Blood pressure increased
Dysgeusia (disorder of the sense of taste)
Ageusia (loss of taste functions of the tongue)
Alopecia (absence of hair from areas of the body)
Dry mouth
Dyspnoea (difficult or laboured respiration)
Headache (pain in head)
Hypoaesthesia oral (reduced sense of touch or sensation in mouth)
Pain
Abdominal pain upper

male:

Chronic kidney disease
Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
Frequent bowel movements
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Intestinal perforation (complete penetration of the wall of the intestine)
Joint range of motion decreased (disease of joint movement)
Lung disorder (lung disease)
Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
Nephrogenic anaemia (anaemia due to kidney disease)
Night sweats (sweating in night)

What are the common drug interactions of Tussionex Pennkinetic and Ergocalciferol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Fatigue (feeling of tiredness)
Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
Osteoporosis (bones weak and more likely to break)
Arthralgia (joint pain)
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Back pain
Bone loss
Cervical radiculopathy (disturbance of nerve function that causes pain in the upper body)
Diarrhoea
Dizziness

50-59:

Hypoaesthesia oral (reduced sense of touch or sensation in mouth)
Abdominal pain upper
Adverse event following immunisation
Ageusia (loss of taste functions of the tongue)
Asthma
Blood glucose increased
Deafness unilateral
Death
Diarrhoea
Dry mouth

60+:

Chronic kidney disease
Renal failure (kidney dysfunction)
Renal injury (kidney injury)
Hypotension (abnormally low blood pressure)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 27.27%
Lung Neoplasm Malignant (cancer tumour of lung): 6 people, 27.27%
Pain: 5 people, 22.73%
Asthma: 4 people, 18.18%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 4 people, 18.18%
Diabetes: 4 people, 18.18%
Lung Cancer - Non-Small Cell (lung cancer): 4 people, 18.18%
Pneumonia: 4 people, 18.18%
Constipation: 3 people, 13.64%
Gastric Ulcer (stomach ulcer): 3 people, 13.64%

* Approximation only. Some reports may have incomplete information.

Do you take Tussionex pennkinetic and Ergocalciferol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously